Eli Lilly (LLY) Long-Term Debt Repayments (2009 - 2026)
Eli Lilly posted quarterly Long-Term Debt Repayments of $750.0 million for Q1 2026, up 750100.0% on a QoQ basis from -$100000.0 in Q4 2025.
Eli Lilly (LLY) has 17 years of Long-Term Debt Repayments data on file, last reported at $750.0 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Debt Repayments changed N/A year-over-year to $750.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 764100.0% YoY), and the FY2025 full-year result was $778.0 million, up 17.17% from the prior year.
- Long-Term Debt Repayments for Q1 2026 stood at $750.0 million, up from -$100000.0 in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $849.9 million in Q2 2022 and bottomed at -$200000.0 in Q4 2024.
- The 4-year median for Long-Term Debt Repayments is $730.0 million (2022), against an average of $514.6 million.
- Peak annual rise in Long-Term Debt Repayments reached 50.0% in 2025, while the deepest fall reached 50.0% in 2025.
- A 4-year view of Long-Term Debt Repayments shows it stood at $849.9 million in 2022, then slumped by 100.02% to -$200000.0 in 2024, then surged by 50.0% to -$100000.0 in 2025, then surged by 750100.0% to $750.0 million in 2026.
- The last three Long-Term Debt Repayments figures came in at $750.0 million (Q1 2026), -$100000.0 (Q4 2025), and $778.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 750.00 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 1.14 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 833.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.77 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 500.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 750.00 Mn |
| Mar 31, 2026 | 750.00 Mn |
| Dec 31, 2025 | -100,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Jun 30, 2025 | 778.10 Mn |
| Jun 30, 2025 | 778.10 Mn |
| Dec 31, 2024 | -200,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Jun 30, 2022 | 849.90 Mn |
| Jun 30, 2022 | 849.90 Mn |
| Mar 31, 2022 | 710.10 Mn |
| Mar 31, 2022 | 710.10 Mn |
| Dec 31, 2021 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 1.91 Bn |
| Sep 30, 2021 | 1.91 Bn |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Mar 31, 2020 | 276.30 Mn |
| Mar 31, 2020 | 276.30 Mn |
| Dec 31, 2019 | 2.27 Bn |
| Dec 31, 2019 | 2.27 Bn |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Mar 31, 2019 | 600.00 Mn |
| Mar 31, 2019 | 600.00 Mn |
| Dec 31, 2018 | 7.60 Mn |
| Dec 31, 2018 | 7.60 Mn |
| Jun 30, 2018 | 201.20 Mn |
| Jun 30, 2018 | 201.20 Mn |
| Mar 31, 2018 | 800.30 Mn |
| Mar 31, 2018 | 800.30 Mn |
| Sep 30, 2017 | 100,000.00 |
| Sep 30, 2017 | 100,000.00 |
| Jun 30, 2017 | 300,000.00 |
| Jun 30, 2017 | 300,000.00 |
| Mar 31, 2017 | 630.20 Mn |
| Mar 31, 2017 | 630.20 Mn |
| Sep 30, 2016 | 100,000.00 |
| Sep 30, 2016 | 100,000.00 |
| Jun 30, 2016 | 100,000.00 |
| Jun 30, 2016 | 100,000.00 |
| Dec 31, 2015 | 5.10 Mn |
| Dec 31, 2015 | 5.10 Mn |
| Sep 30, 2015 | -900,000.00 |
| Sep 30, 2015 | -900,000.00 |
| Jun 30, 2015 | 1.95 Bn |
| Jun 30, 2015 | 1.95 Bn |
| Mar 31, 2015 | 1.50 Mn |
| Mar 31, 2015 | 1.50 Mn |
| Dec 31, 2014 | 500,000.00 |
| Dec 31, 2014 | 500,000.00 |
| Sep 30, 2014 | 500,000.00 |
| Sep 30, 2014 | 500,000.00 |
| Jun 30, 2014 | 33.80 Mn |
| Jun 30, 2014 | 33.80 Mn |
| Mar 31, 2014 | 1.00 Bn |
| Mar 31, 2014 | 1.00 Bn |
| Dec 31, 2013 | 7.50 Mn |
| Dec 31, 2013 | 7.50 Mn |
| Sep 30, 2013 | 1.30 Mn |
| Sep 30, 2013 | 1.30 Mn |
| Jun 30, 2013 | 800,000.00 |
| Jun 30, 2013 | 800,000.00 |
| Mar 31, 2013 | 900,000.00 |
| Mar 31, 2013 | 900,000.00 |
| Dec 31, 2012 | 2.60 Mn |
| Dec 31, 2012 | 2.60 Mn |
| Sep 30, 2012 | 500,000.00 |
| Sep 30, 2012 | 500,000.00 |
| Jun 30, 2012 | 900,000.00 |
| Jun 30, 2012 | 900,000.00 |
| Mar 31, 2012 | 1.51 Bn |
| Mar 31, 2012 | 1.51 Bn |
| Dec 31, 2011 | 7.10 Mn |
| Dec 31, 2011 | 7.10 Mn |
| Mar 31, 2011 | 54.60 Mn |
| Mar 31, 2011 | 54.60 Mn |
| Dec 31, 2010 | 400,000.00 |
| Dec 31, 2010 | 400,000.00 |
| Sep 30, 2010 | 1.40 Mn |
| Sep 30, 2010 | 1.40 Mn |
| Jun 30, 2010 | -700,000.00 |
| Jun 30, 2010 | -700,000.00 |
| Dec 31, 2009 | -400.00 Mn |
| Dec 31, 2009 | -400.00 Mn |
| Sep 30, 2009 | 400.00 Mn |
| Sep 30, 2009 | 400.00 Mn |